Logo

Kathy Ordoñez

Nov 03, 2017

Pacific Biosciences has hired Kathy Ordoñez as chief commercial officer. Ordoñez has been a member of PacBio's board of directors since 2014 and will continue in that role, as well. Ordoñez was most recently CEO of RainDance Technologies. She was also previously senior vice president at Quest Diagnostics where she led the company's R&D efforts and provided oversight to businesses commercializing diagnostic products and testing services. She served as CEO at Celera and was a founder of Celera Diagnostics before the company was acquireid by Quest Diagnostics. She also held several positions at Hoffmann-La Roche, including overseeing the formation of Roche Molecular Systems.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.